| | Stimulation | Change | Tissue | Reference |
| | Cytokines | | | | | IFN-α | increase | CEM, Jurkat, and THP-1 cells | [26] | | IFN-α | increase | H9 cells | [47] | | IFN-α | increase | HepG2 cells | [13] | | IFN-α | increase | Primary MDM | [24] | | IFN-α | increase | U937 | [25] | | IFN-α | increase | U-937-4 cells | [46] | | IFN-α/β | increase | Daudi, and HeLa cells | [45] | | IFN-β | increase | HOS cells | [14] | | IFN-γ | increase | HeLa cells | [30, 45] | | IFN-γ | increase | HepG2 cells | [13, 48, 49] | | IFN-γ | increase | MCF7 cells | [30] | | IL-1-β | increase | Coronary artery endothelium | [58] | | IL-2 | increase | CD4+, CD8+, NK cells | [50] | | IL-15 | increase | CD4+, CD8+, NK cells | [50] | | Progesterone | increase | ABC28, and T47D cells | [30] | | TNF-α | increase | Coronary artery endothelium | [58] |
| | Antigens/Infections | | | | | EBV infection1 | increase | BL41-EBV cells1 | [55] | | EBV LMP-1 | increase | DG75 cells | [55] | | Hepatitis B virus infection2 | increase | Liver tissue2 | [51] | | Hepatitis C virus infection2 | increase | Liver tissue2 | [52] | | Hepatitis C virus infection | increase | Liver tissue | [53] | | HIV-1 infection | increase | Immature DC | [55] | | HIV-1 infection | increase | Primary MDM | [24] | | HIV-1 infection | increase | Primary PBMCs | [26] | | HIV-1 Tat | increase | Immature DC | [55] | | HPV infection | decrease | Human keratinocytes | [56] | | KSHV infection | increase | KSHV lesion | [57] | | KSHV LANA | increase | BJAB cells | [57] | | LPS | increase | Primary MDM | [24] | | Rubella virus infection | increase | ECV304 cells | [54] |
| | Activation/Differentiation/Cell Cycle | | | | | 1α,25-dihydroxyvitamine D33 | increase | Primary MDM | [24] | | Anti-CD2 | increase | Primary T cells | [47] | | Anti-CD2/CD28 | decrease | Primary T cells | [47] | | Anti-CD2/CD28/CD3 | decrease | CD4+, CD8+, NK cells4 | [50] | | All-trans retinoic acid | increase | HL60 and NB4 cells | [46] | | All-trans retinoic acid | increase | Primary MDM | [24] | | p53 | increase | K562 and U-937-4 cells5 | [46] | | p73 | increase | U-937-4 cells | [46] | | Pioglitazone | increase | Primary MDM | [24] | | UV-irradiation6 | increase | MCF-7 cells | [46] |
| | Disease | | | | | SLE | decrease | CD4+ T cells from SLE patient | [59] | | Wilms tumor | decrease | Tumor tissue | [60, 61] |
|
|